This enhancement was more evident in Ig HC variable region (IGHV)-mutated, better prognostic, CD38− or early Rai-stage CLL than in IGHV-unmutated, poor prognostic, CD38+ or advanced Rai-stage CLL (89). Here, CD38 is linked to B-cell chronic lymphocytic leukemia.